Align Technology stock (NASDAQ
NDAQ
: ALGN), best known for its Invisalign dental aligners, currently trades at $300 per share, 45% below the level seen in March 2021, and it looks undervalued. ALGN stock was trading at around $237 in early June 2022, just before the Fed started increasing rates, and is now 26% above that level, compared to 13% gains for the S&P 500 during this period. The rally in the stock over recent months has been driven by a steady decline in the inflation rate in response to the Fed’s aggressive rate hike plan – although investors still have concerns about a potential recession.
Interestingly, ALGN stock has had a Sharpe Ratio of 0.5 since early 2017, slightly lower than 0.6 for the S&P 500 Index over the same period. This compares with the Sharpe of 1.3 for the Trefis Reinforced Value portfolio. Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.
Subscribe
Gain access to all our Premium contents.
More than 100+ articles.
Buy Article
Unlock this article and gain permanent access to read it.